Vistagen Therapeutics (VTGN) Set to Announce Earnings on Tuesday

Vistagen Therapeutics (NASDAQ:VTGNGet Free Report) is scheduled to post its quarterly earnings results after the market closes on Tuesday, June 11th. Analysts expect Vistagen Therapeutics to post earnings of ($0.34) per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link.

Vistagen Therapeutics Stock Down 1.8 %

Vistagen Therapeutics stock opened at $3.79 on Friday. The business has a 50 day moving average price of $4.57 and a two-hundred day moving average price of $4.67. Vistagen Therapeutics has a 12 month low of $1.62 and a 12 month high of $24.71.

Vistagen Therapeutics Company Profile

(Get Free Report)

Vistagen Therapeutics, Inc, a late clinical-stage biopharmaceutical company, primarily focus to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders. The company's pipeline includes six clinical stage product candidates, including five investigational agents belonging to drugs known as pherines.

See Also

Earnings History for Vistagen Therapeutics (NASDAQ:VTGN)

Receive News & Ratings for Vistagen Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vistagen Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.